Single award · contract
Monoclonal Antibody LY-COV555
Award ID: W911QY21C0016
FY2021 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$1.4B
Total award value
Award W911QY21C0016 is a contract from the Department of Defense to Eli Lilly and Company, $1.4B obligated, FY2021, for Monoclonal Antibody LY-COV555. The work is performed in Indiana. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Agency ›
Department of Defense
Source
awarded→$1.4B
Recipient ›
Eli Lilly and Company
Source
performed in→
Award details
Award typeContract
PIIDW911QY21C0016
Action date2020
Period8 mo
Awarding agencyDepartment of Defense →
RecipientEli Lilly and Company →
Place of performanceIndiana →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$1,373,930,000
More awards to Eli Lilly and Company
awarded 2022$1.5B
awarded 2021$329.8M
awarded 2021$210M
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.